GNAT3 and type 2 diabetes mellitus: Specifically, T2DM patients treated with metformin had significantly higher levels of TCDCA, TDCA, HDCA, GDCA, GLCA and DCA when compared with both non-diabetic subjects and T2DM patients who were not treated with metformin.